CLINICAL STUDY OF DL-8280

Abstract

DL-8280, 200 to 900 mg/day, was administered orally to 20 patients with respiratory tract infection. Clinical effects were excellent in 2 patients, good in 12, fair in 2, and undetermined in 4, thus overall efficacy being 87.5%. A headache, an eruption, or an epigastralgia occurred individually in 3 cases as side effects. However, those symptomes disappeared immediately after discontinuation of the administration without any special treatments. No abnormal findings were disclosed by laboratory examination as well.